Ana Alarcon Tomas (Ana Alarcón)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Prognostic Factors

Top Venues

Bone marrow transplantation

Nature medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Gustav Cederquist, Javin Schefflein, Sean M Devlin, Gunjan L Shah, Roni Shouval, Harper Hubbeling, Kathryn R Tringale, Ana Alarcon Tomas, Beatrice Fregonese, Carla Hajj, Alexander P Boardman, Alejandro Luna De Abia, Magdalena Corona, Giulio Cassanello, Parastoo B Dahi, Richard J Lin, Paola Ghione, Gilles Andre Salles, Miguel-Ángel Perales, Maria Lia Palomba, Lorenzo Falchi, Michael Scordo, Christian Grommes, Joachim Yahalom, Brandon S Imber
CNS Bridging Radiotherapy Achieves Rapid Cytoreduction Prior to CAR T Cell Therapy for Aggressive B-Cell Lymphoma. Blood advances (2024)
Harper G Hubbeling, Doris Leithner, Emily A Silverman, Jessica R Flynn, Sean M Devlin, Gunjan L Shah, Beatrice Fregonese, Beatriz Wills, Akshay S Bedmutha, Ana Alarcon Tomas, Allison Parascondola, Amethyst Saldia, Ivan Landego, Carla Hajj, Alexander P Boardman, Parastoo Bahrami Dahi, Arnab Ghosh, Sergio A Giralt, Richard J Lin, Jae H Park, Michael Scordo, Gilles Andre Salles, Joachim Yahalom, Maria Lia Palomba, Heiko Schöder, Miguel-Ángel Perales, Roni Shouval, Brandon S Imber
Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B cell lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Gustav Cederquist, Javin Schefflein, Sean M Devlin, Gunjan L Shah, Roni Shouval, Harper Hubbeling, Kathryn R Tringale, Ana Alarcon Tomas, Beatrice Fregonese, Carla Hajj, Alexander P Boardman, Alejandro Luna De Abia, Magdalena Corona, Giulio Cassanello, Parastoo B Dahi, Richard J Lin, Paola Ghione, Gilles Andre Salles, Miguel-Ángel Perales, Maria Lia Palomba, Lorenzo Falchi, Michael Scordo, Christian Grommes, Joachim Yahalom, Brandon S Imber
CNS Bridging Radiotherapy Achieves Rapid Cytoreduction Prior to CAR T Cell Therapy for Aggressive B-Cell Lymphoma. Blood advances (2024)
Miriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, Molly Maloy, Samira A Fatmi, Ana Alarcon Tomas, Silvia Escribano-Serrat, Doris M Ponce, Craig S Sauter, Sergio A Giralt, Michael Scordo, Miguel-Ángel Perales
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2023)
Miriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, Molly Maloy, Samira A Fatmi, Ana Alarcon Tomas, Silvia Escribano-Serrat, Doris M Ponce, Craig S Sauter, Sergio A Giralt, Michael Scordo, Miguel-Ángel Perales
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2023)
Richard J Lin, Soo Jung Kim, Samantha Brown, Theresa A Elko, Josel D Ruiz, Danielle M Hanley, M Lia Palomba, Miguel-Ángel Perales, Gunjan L Shah, Parastoo B Dahi, Michael Scordo, Craig S Sauter, Connie Lee Batlevi, Ana Alarcon Tomas, Roni Shouval, Nicole Lee, Emma A Pavkovic, Danielle E Engstler, Jae H Park, Gilles Andre Salles, Sean M Devlin, Beatriz Korc-Grodzicki, Paul A Hamlin, Sergio A Giralt
Prospective Geriatric Assessment and Geriatric Consultation in CAR T-cell Therapy for Older Lymphoma Patients. Blood advances (2023)
Michael Scordo, Jessica R Flynn, Mithat Gönen, Sean M Devlin, Allison Parascondola, Ana Alarcon Tomas, Roni Shouval, Jamie Brower, David L Porter, Stephen J Schuster, Veronika Bachanova, Joseph Maakaron, Richard T Maziarz, Andy I Chen, Loretta J Nastoupil, Joseph P McGuirk, Olalekan O Oluwole, Andrew Ip, Lori A Leslie, Michael R Bishop, Peter A Riedell, Miguel-Ángel Perales
Identifying an Optimal Fludarabine Exposure for Improved Outcomes after CD19 CAR T cell therapy for Aggressive B-NHL. Blood advances (2023)
Jae H Park, Karthik Nath, Sean M Devlin, Craig S Sauter, Maria Lia Palomba, Gunjan Shah, Parastoo Dahi, Richard J Lin, Michael Scordo, Miguel-Ángel Perales, Roni Shouval, Ana Alarcon Tomas, Elizabeth Cathcart, Elena Mead, Bianca D Santomasso, Andrei I Holodny, Renier J Brentjens, Isabelle Riviere, Michel Sadelain
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results. Nature medicine (2023)
Ana Alarcon Tomas, Joshua Alexander Fein, Shalev Fried, Jessica R Flynn, Sean M Devlin, Warren B Fingrut, Theodora Anagnostou, Anna Alperovich, Nishi Shah, Ellen Fraint, Richard J Lin, Michael Scordo, Connie Lee Batlevi, Michal J Besser, Parastoo Bahrami Dahi, Ivetta Danylesko, Sergio A Giralt, Brandon S Imber, Elad Jacoby, Meirav Kedmi, Arnon Nagler, Maria Lia Palomba, Mikhail Roshal, Gilles A Salles, Craig Sauter, Noga Shem-Tov, Avichai Shimoni, Joachim Yahalom, Ronit Yerushalmi, Gunjan L Shah, Abraham Avigdor, Miguel-Ángel Perales, Roni Shouval
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma. Leukemia (2022)
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, Sean M Devlin, Jamie Brower, Veronika Bachanova, Loretta J Nastoupil, Joseph P McGuirk, Richard T Maziarz, Olalekan O Oluwole, Stephen J Schuster, David L Porter, Michael R Bishop, Peter A Riedell, Miguel-Ángel Perales
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy. Blood advances (2022)
Magdalena Corona, Roni Shouval, Ana Alarcon Tomas, Jessica Flynn, Sean Devlin, Connie Lee Batlevi, Simon Mantha, Maria Lia Palomba, Michael Scordo, Gunjan L Shah, Craig Sauter, Miguel-Ángel Perales, Parastoo Bahrami Dahi
Management of prolonged cytopenia following CAR T-cell therapy. Bone marrow transplantation 57 (12) (2022)
Shakthi T Bhaskar, Vivek G Patel, David L Porter, Stephen J Schuster, Loretta J Nastoupil, Miguel-Ángel Perales, Ana Alarcon Tomas, Michael R Bishop, Joseph P McGuirk, Richard T Maziarz, Andy Chen, Veronika Bachanova, Joseph Maakaron, Peter A Riedell, Olalekan O Oluwole
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome. Blood advances (2022)
Roni Shouval, Joshua Alexander Fein, Christina Cho, Scott T Avecilla, Josel D Ruiz, Ana Alarcon Tomas, Miriam Sanchez-Escamilla, Nerea Castillo Flores, Lucrecia Yáñez, Juliet N Barker, Parastoo Bahrami Dahi, Sergio A Giralt, Alexander Geyer, Boglarka Gyurkocza, Ann A Jakubowski, Richard J Lin, Richard J O'Reilly, Esperanza B Papadopoulos, Ioannis Politikos, Doris M Ponce, Craig S Sauter, Michael Scordo, Brian Shaffer, Gunjan Shah, James P Sullivan, Roni Tamari, Marcel R M Rm van den Brink, James W Young, Arnon Nagler, Sean M Devlin, Avichai Shimoni, Miguel-Ángel Perales
The Simplified Comorbidity Index (SCI) - a new tool for prediction of non-relapse mortality in allogeneic HCT. Blood advances (2021)
Ana Alarcon Tomas, Karissa Whiting, Molly Maloy, Josel D Ruiz, Sean Devlin, Miriam Sanchez-Escamilla, Lucrecia Yañez, Nerea Castillo, Martina Pennisi, Christina Cho, Brian Shaffer, Hugo Castro-Malaspina, Virginia Klimek, Sergio A Giralt, Roni Tamari, Miguel-Ángel Perales
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant. Bone marrow transplantation 56 (11) (2021)
Roni Shouval, Ana Alarcon Tomas, Joshua Alexander Fein, Jessica R Flynn, Ettai Markovits, Shimrit Mayer, Aishat Olaide Afuye, Anna Alperovich, Theodora Anagnostou, Michal J Besser, Connie Lee Batlevi, Parastoo B Dahi, Sean M Devlin, Warren B Fingrut, Sergio A Giralt, Richard J Lin, Gal Markel, Gilles Andre Salles, Craig S Sauter, Michael Scordo, Gunjan L Shah, Nishi Shah, Ruth Scherz-Shouval, Marcel van den Brink, Miguel-Ángel Perales, Maria Lia Palomba
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Martina Pennisi, Miriam Sanchez-Escamilla, Jessica R Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynn Silverberg, Connie Lee Batlevi, Renier J Brentjens, Parastoo Bahrami Dahi, Sean M Devlin, Claudia Diamonte, Sergio A Giralt, Elizabeth F Halton, Tania Jain, Molly Maloy, Elena Mead, Maria Lia Palomba, Josel Ruiz, Bianca Santomasso, Craig S Sauter, Michael Scordo, Gunjan L Shah, Jae H Park, Lucrecia Yáñez, Miguel-Ángel Perales
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood advances 5 (17) (2021)